Prognostic value of FDG-PET/CT in recurrent/refractory CNS lymphoma receiving Ibrutinib-based therapies

journal contribution

posted on 2025-04-09, 04:30 authored by Shiri KrebsShiri Krebs, J Wolfe, I Mellinghoff, C Grommes, H Schoder

Prognostic value of FDG-PET/CT in recurrent/refractory CNS lymphoma receiving Ibrutinib-based therapies

History

Journal

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Volume

46

Pagination

S260-S261

Location

SPAIN, Barcelona

ISSN

1619-7070

eISSN

1619-7089

Language

English

Publication classification

E3.1 Extract of paper

Issue

SUPPL 1

Publisher

SPRINGER

Usage metrics

Categories

Keywords

Science & Technology Life Sciences & Biomedicine Radiology, Nuclear Medicine & Medical Imaging

Licence

All Rights Reserved

Exports